76 related articles for article (PubMed ID: 16423356)
1. Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.
Valenta DT; Bulgrien JJ; Banka CL; Curtiss LK
Atherosclerosis; 2006 Dec; 189(2):255-63. PubMed ID: 16423356
[TBL] [Abstract][Full Text] [Related]
2. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
Moore RE; Kawashiri MA; Kitajima K; Secreto A; Millar JS; Pratico D; Rader DJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1914-20. PubMed ID: 12933536
[TBL] [Abstract][Full Text] [Related]
4. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice.
Plummer MR; Hasty AH
J Nutr Biochem; 2008 Oct; 19(10):664-73. PubMed ID: 18280133
[TBL] [Abstract][Full Text] [Related]
7. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
[TBL] [Abstract][Full Text] [Related]
8. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
Li H; Gu S; She M
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
[TBL] [Abstract][Full Text] [Related]
10. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
11. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
Valenta DT; Bulgrien JJ; Bonnet DJ; Curtiss LK
J Lipid Res; 2008 Jan; 49(1):24-32. PubMed ID: 17928634
[TBL] [Abstract][Full Text] [Related]
12. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
Li H; Gu S; Cao X; Wang Z; She M
Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
[TBL] [Abstract][Full Text] [Related]
13. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
Kawashiri MA; Zhang Y; Puré E; Rader DJ
Atherosclerosis; 2002 Nov; 165(1):15-22. PubMed ID: 12208466
[TBL] [Abstract][Full Text] [Related]
15. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
Lian J; Quiroga AD; Li L; Lehner R
Circ Res; 2012 Sep; 111(8):982-90. PubMed ID: 22872154
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.
Lebherz C; Sanmiguel J; Wilson JM; Rader DJ
Cardiovasc Diabetol; 2007 May; 6():15. PubMed ID: 17475009
[TBL] [Abstract][Full Text] [Related]
17. [Effect of oxLDL on the uptake and clearance rate of cholesterol in vascular smooth muscle cells originated from human apoAI transgenic mice].
Zeng Y; Zhao GF; Qian J; Wang ZL; She MP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):328-32. PubMed ID: 12940070
[TBL] [Abstract][Full Text] [Related]
18. Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
Andersson KE; Svedberg KA; Lindholm MW; Oste R; Hellstrand P
Atherosclerosis; 2010 Sep; 212(1):93-9. PubMed ID: 20553794
[TBL] [Abstract][Full Text] [Related]
19. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice.
Gruen ML; Saraswathi V; Nuotio-Antar AM; Plummer MR; Coenen KR; Hasty AH
Atherosclerosis; 2006 May; 186(1):54-64. PubMed ID: 16102772
[TBL] [Abstract][Full Text] [Related]
20. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
Stein CS; Martins I; Davidson BL
J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
